Skip to main content

Phosphate-Restricted Diets versus Calcitonin in the Prevention of Osteodystrophy in Experimental Renal Disease

  • Chapter
Phosphate and Mineral Metabolism

Abstract

Restriction of dietary phosphate intake is beneficial in preventing the development of secondary hyperparathyroidism and bone disease in experimental renal failure in the dog (l–3). If associated with vitamin D administration, this dietary regimen can prevent both pathologic bone resorption and osteomalacia in the same experimental model (3). In rats with surgically-induced renal failure, the administration of phosphate-deficient diets (0.03% phosphate) is followed by anorexia, hypophosphatemia, growth arrest, stunting, and severe rickets (4,5). On the other hand, growth failure is also commonly observed when the same animals are given high-phosphate diets (1.58 % phosphate) (6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. SLATOPOLSKY E., CAGLAR S., PENNELL J.P., TAGGART D.D., CANTERBURY J. M., REISS E., BRICKER N.S.: On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J.Clin.Invest. 50, 422–499, 1971.

    Article  Google Scholar 

  2. SLATOPOLSKY E., CAGLAR S., GRADOWSKA L., CANTERBURY J., REISS E., BRICKER N.S.: On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake. Kidney Intern. 2, 147151, 1972.

    Google Scholar 

  3. RUTHERFORD W.E., BORDIER P., MARIE P., HRUSKA K., HARTER H., GREENWALT A., BLONDIN J., HADDAD J., BRICKER N., SLATOPOLSKY E.: Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J.Clin. Invest. 60, 332–341, 1977.

    Article  CAS  Google Scholar 

  4. SALUSKY I., KLEINKNECHT C., BROYER M., GUBLER M.-C.: Prolonged renal survival and stunting with protein-deficient diets in experimental uremia. J.Lab.Clin.Med. 97, 21–30, 1981.

    PubMed  CAS  Google Scholar 

  5. LAOUARI D., KLEINKNECHT C., COURNOT-WITMER G., HABIB R., BROYER M.: Importance of anorexia in the preservation of renal function due to deficient phosphorus diets. Third Intern.Congr.Nutrition and Metabolism in Renal Disease,Abstract Book,n. 89, 1982.

    Google Scholar 

  6. KLEINKNECHT C., SALUSKY I., BROYER M., GUBLER M.-C.: Effect of various protein diets on growth, renal function, and survival of uremic rats. Kidney Intern. 15, 534–541, 1979.

    Article  CAS  Google Scholar 

  7. FELETTI C., DOCCI D., CAPELLI M., BONOMINI V.: Pathophysiology of endogenous calcitonin in chronic uremia. Min.Electrol.Metab. 6, 174–181, 1981.

    Google Scholar 

  8. HEYNEN G., KANIS J.A., OLIVER D., LEDINGHAM J.G.G., RUSSELL R.G.G.: Evidence that endogenous calcitonin protects against renal bone disease. Lancet 2, 1322–1326, 1976.

    Article  Google Scholar 

  9. KANIS J.A., EARNSSHAW M., HEYNEN J., RUSSELL R.G.G., WOODS C.G.:The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure. Calcif.Tissue Res. 22, 147–153, 1977.

    Article  PubMed  Google Scholar 

  10. HABENER F., SCHILLER A.L.: Pathogenesis of renal osteodystrophy: a role for calcitonin ? New Engl.J.Med. 296, 1112–1113, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. FELETTI C., BONOMINI V.: Effect of calcitonin on bone lesions in chronic dialysis patients. Nephron 24, 85–88, 1979.

    Article  PubMed  CAS  Google Scholar 

  12. FARRINGTON K., VARGHESE Z., MOORHEAD J.F.: Human calcitonin in the treatment of renal osteodystrophy. J.Labor.Clin.Med. 96, 299–306, 1980.

    CAS  Google Scholar 

  13. CUNDY T., KANIS J.A., HEYNEN G., PATON S., EARNSHAW M., WOODS C.G.: Deterioration of renal bone disease in patients treated with salmon calcitonin. Clin.Endocrinol. 16, 29–37, 1982.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

D’Angelo, A. et al. (1984). Phosphate-Restricted Diets versus Calcitonin in the Prevention of Osteodystrophy in Experimental Renal Disease. In: Massry, S.G., Maschio, G., Ritz, E. (eds) Phosphate and Mineral Metabolism. Advances in Experimental Medicine and Biology, vol 178. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4808-5_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4808-5_32

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4810-8

  • Online ISBN: 978-1-4684-4808-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics